Market Overview:
The global liver cancer diagnostic tests market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of liver cancer, rising awareness about early diagnosis and treatment options, and technological advancements in diagnostic tests. Based on type, the global liver cancer diagnostic tests market is segmented into reagent and instrument. The reagent segment is further sub-segmented into antibodies, enzymes, histology kits, and other reagents. The instrument segment is further sub-segmented into imaging systems (CT scanners, MRI scanners), spectroscopy systems (NIRS), and other instruments. Based on application, the global liver cancer diagnostic tests market is divided into hospital laboratories, physical examination centers/clinics/outpatient settings,, research laboratories/academic institutions,, veterinary clinics,,and other applications such as point-of-care testing (POCT) devices).
Product Definition:
There are a number of liver cancer diagnostic tests that are used to diagnose the disease. These tests include blood tests, imaging scans, and biopsies. Blood tests can be used to detect tumor markers, which are proteins that are released by tumors. Imaging scans can be used to see if there is a mass or tumor in the liver. A biopsy is when a sample of tissue is taken from the liver and examined under a microscope to see if it contains cancer cells. The importance of these diagnostic tests is that they can help doctors determine whether or not someone has liver cancer and what stage the disease is at.
Reagent:
Reagents are chemicals that help in detecting or identifying a particular disease condition. Reagents can be categorized into two types, those which are specific for the disease and those which serve as a generic test. For instance, HGB-200 is specific for hemoglobin disorders while HGB-30 is used to detect liver cancer.
Instrument:
The global market for instrument and it's usage in liver cancer diagnostic tests is expected to witness significant growth over the forecast period. Increasing prevalence of hepatocellular carcinoma (HCC) coupled with rising demand for accurate, rapid, sensitive & multiplexed diagnostic tests are major drivers of this market. According to the American Cancer Society’s Cancer Statistics Center, Inc., HCC accounted for approximately 8% of all cancers diagnosed in the U.
Application Insights:
The other application segment includes research studies and others. Other applications include research studies, which accounted for the largest revenue share in 2017 owing to an increase in prevalence of chronic liver diseases such as non-alcoholic Steatohepatitis (NASH) and primary biliary cirrhosis (PBC). NASH is a common disease affecting people aged over 40 years; it is also prevalent among people who drink alcohol excessively. PBC affects around 1% to 2% of the population every year; however, only 10% of these cases are diagnosed due to lack of awareness about the condition amongst patients as well as healthcare professionals. Diagnostic tests are thus required for early detection of liver cancer, which will help reduce its progression and impact on society at large through increased productivity.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of liver cancer diagnostics manufacturers and well-established healthcare infrastructure. Moreover, increasing prevalence of hepatitis B & C infections is also expected to boost demand for liver cancer diagnostic tests in this region. For instance, according to CDC’s National Center for Health Statistics (NCHS), from 2015 to 2016, an estimated 671,000 people were diagnosed with hepatitis B virus infection and 895 die due to it in U.S.
Asia Pacific is expected to grow at the fastest pace during the forecast period due its rapidly developing economy coupled with rising disposable income levels among middle-class populations especially in India and China.
Growth Factors:
- Increasing incidence of liver cancer
- Growing demand for early diagnosis of liver cancer
- Rising awareness about the benefits of early detection of liver cancer
- Technological advancements in diagnostic tests for liver cancer
- Growing number of clinical studies on diagnostics for liver cancer
Scope Of The Report
Report Attributes
Report Details
Report Title
Liver Cancer Diagnostic Tests Market Research Report
By Type
Reagent, Instrument
By Application
Hospital, Physical Examination Center, Other
By Companies
Abbott Diagnostics, Abcodia, BioMark Technologies, AXO Science SAS, Bioprognos SL, China Sky One Medica, Digna Biotech SL, Glycotest
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
201
Number of Tables & Figures
141
Customization Available
Yes, the report can be customized as per your need.
Global Liver Cancer Diagnostic Tests Market Report Segments:
The global Liver Cancer Diagnostic Tests market is segmented on the basis of:
Types
Reagent, Instrument
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Physical Examination Center, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Diagnostics
- Abcodia
- BioMark Technologies
- AXO Science SAS
- Bioprognos SL
- China Sky One Medica
- Digna Biotech SL
- Glycotest
Highlights of The Liver Cancer Diagnostic Tests Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Reagent
- Instrument
- By Application:
- Hospital
- Physical Examination Center
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Liver Cancer Diagnostic Tests Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
There are a number of diagnostic tests that can be used to diagnose liver cancer. These tests include:nn-A blood test to check for levels of the cancer marker CA 15-3 in the blood; this is often used as a screening test for liver cancer, but it cannot always confirm whether or not someone has the disease.n-An ultrasound exam to look at the size and shape of the liver; this can help determine if there is any evidence of tumor growth in the organ.n-A CT scan or MRI scan (magnetic resonance imaging) to see if there is any evidence of tumor growth inside or outside of the liver.
Some of the major players in the liver cancer diagnostic tests market are Abbott Diagnostics, Abcodia, BioMark Technologies, AXO Science SAS, Bioprognos SL, China Sky One Medica, Digna Biotech SL, Glycotest.
The liver cancer diagnostic tests market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Liver Cancer Diagnostic Tests Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Liver Cancer Diagnostic Tests Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Liver Cancer Diagnostic Tests Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Liver Cancer Diagnostic Tests Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Liver Cancer Diagnostic Tests Market Size & Forecast, 2018-2028
4.5.1 Liver Cancer Diagnostic Tests Market Size and Y-o-Y Growth
4.5.2 Liver Cancer Diagnostic Tests Market Absolute $ Opportunity
Chapter 5 Global Liver Cancer Diagnostic Tests Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Liver Cancer Diagnostic Tests Market Size Forecast by Type
5.2.1 Reagent
5.2.2 Instrument
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Liver Cancer Diagnostic Tests Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Liver Cancer Diagnostic Tests Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Physical Examination Center
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Liver Cancer Diagnostic Tests Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Liver Cancer Diagnostic Tests Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Liver Cancer Diagnostic Tests Analysis and Forecast
9.1 Introduction
9.2 North America Liver Cancer Diagnostic Tests Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Liver Cancer Diagnostic Tests Market Size Forecast by Type
9.6.1 Reagent
9.6.2 Instrument
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Liver Cancer Diagnostic Tests Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Physical Examination Center
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Liver Cancer Diagnostic Tests Analysis and Forecast
10.1 Introduction
10.2 Europe Liver Cancer Diagnostic Tests Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Liver Cancer Diagnostic Tests Market Size Forecast by Type
10.6.1 Reagent
10.6.2 Instrument
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Liver Cancer Diagnostic Tests Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Physical Examination Center
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Liver Cancer Diagnostic Tests Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Liver Cancer Diagnostic Tests Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Liver Cancer Diagnostic Tests Market Size Forecast by Type
11.6.1 Reagent
11.6.2 Instrument
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Liver Cancer Diagnostic Tests Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Physical Examination Center
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Liver Cancer Diagnostic Tests Analysis and Forecast
12.1 Introduction
12.2 Latin America Liver Cancer Diagnostic Tests Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Liver Cancer Diagnostic Tests Market Size Forecast by Type
12.6.1 Reagent
12.6.2 Instrument
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Liver Cancer Diagnostic Tests Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Physical Examination Center
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Liver Cancer Diagnostic Tests Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Liver Cancer Diagnostic Tests Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Liver Cancer Diagnostic Tests Market Size Forecast by Type
13.6.1 Reagent
13.6.2 Instrument
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Liver Cancer Diagnostic Tests Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Physical Examination Center
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Liver Cancer Diagnostic Tests Market: Competitive Dashboard
14.2 Global Liver Cancer Diagnostic Tests Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Diagnostics
14.3.2 Abcodia
14.3.3 BioMark Technologies
14.3.4 AXO Science SAS
14.3.5 Bioprognos SL
14.3.6 China Sky One Medica
14.3.7 Digna Biotech SL
14.3.8 Glycotest
